PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • PDR Drug Communications are designed to improve the speed and efficacy of the delivery of PDR Drug Alerts, Recalls and Approvals to physicians, prescribers, and their staff.

    Below are the PDR Drug Communications that have been issued by PDR Network. To view the communication details, click on the Medication name.

    If you have trouble accessing Alert details, click to get the latest version of the free Adobe Acrobat Reader software for your computer.

    Filter results by:

    Results 101-120 of 134

    September 10, 2013 Drug Approval:

    Latuda (lurasidone HCl)

    Sunovion Pharmaceuticals

    August 12, 2013 Drug Alert: Important Drug Warning

    Zelboraf® (vemurafenib)

    Genentech

    July 26, 2013 Drug Alert: Important Drug Warning

    ASTAGRAF XL(TM) (tacrolimus extended-release capsules)

    Astellas Pharma

    July 19, 2013 Drug Alert: Important Drug Warning

    Brilinta® (ticagrelor)

    AstraZeneca

    July 08, 2013 Drug Alert: Important Drug Information

    ER/LA Opioid Analgesics

    Various

    June 26, 2013 Drug Alert: Important Drug Warning

    Gilenya® (fingolimod)

    Novartis Pharmaceuticals Corporation

    June 07, 2013 Drug Alert: Important Drug Warning

    BONIVA® Injection (ibandronate sodium)

    Genentech

    June 05, 2013 Drug Alert: Important Drug Warning

    Brilinta® (ticagrelor)

    AstraZeneca

    May 17, 2013 Drug Alert: Important Prescribing Information

    ACTEMRA® (tocilizumab)

    Genentech

    May 03, 2013 Drug Alert: Important Drug Warning

    Xeljanz® (tofacitinib)

    Pfizer Inc

    April 29, 2013 Drug Alert: Important Drug Warning

    Avastin® (bevacizumab)

    Genentech

    March 05, 2013 Drug Alert: Important Drug Warning

    BRILINTA(TM) (ticagrelor)

    AstraZeneca

    February 28, 2013 Drug Alert: Important Prescribing Information

    INVIRASE® (saquinavir mesylate)

    Genentech

    January 22, 2013 Drug Alert: REMS CME Information

    ER/LA Opioid Analgesics

    Various

    January 16, 2013 Drug Alert: Important Safety and Prescribing Information

    Cometriq (TM) (cabozantinib)

    Exelixis, Inc.

    December 04, 2012 Drug Approval:

    RECTIV® (nitroglycerin)

    Aptalis

    November 20, 2012 Drug Alert: Important Drug Warning

    XELJANZ® (tofacitinib)

    Pfizer Inc

    November 20, 2012 Drug Approval:

    Lyrica (pregabalin)

    Pfizer Pharmaceuticals LLC

    October 23, 2012 Drug Alert: Important Prescribing Information

    ACTEMRA® (tocilizumab)

    Genentech

    Results 101-120 of 134